A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorect... von Tol, J., Koopman, M., Rodenburg, C. J., Cats, A., Creemers, G. J., Schrama, J. G., Erdkamp, F. L. G., Vos, A. H., Mol, L., Antonini, N. F., Punt, C. J. A.

Volltext

A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithel... von Reyners, A.K.L., de Munck, L., Erdkamp, F.L.G., Smit, W.M., Hoekman, K., Lalisang, R.I., de Graaf, H., Wymenga, A.N.M., Polee, M., Hollema, H., van Vugt, M.A.T.M., Schaapveld, M., Willemse, P.H.B.

Volltext

Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 st... von Goey, K.K.H., Elias, S.G., van Tinteren, H., Laclé, M.M., Willems, S.M., Offerhaus, G.J.A., de Leng, W.W.J., Strengman, E., ten Tije, A.J., Creemers, G.-J. M., van der Velden, A., de Jongh, F.E., Erdkamp, F.L.G., Tanis, B.C., Punt, C.J.A., Koopman, M.

Volltext

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy von Lalisang, R. I., Erdkamp, F. L. G., Rodenburg, C. J., Knibbeler-van Rossum, C. T. A. M., Nortier, J. W. R., van Bochove, A., Slee, P. H. Th. J., Voest, E. E., Wils, J. A., Wals, J., Loosveld, O. J. L., Smals, A. E. M., Blijham, G. H., Tjan-Heijnen, V. C. G., Schouten, H. C.

Volltext

Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colo... von Koopman, M, Antonini, NF, Douma, J, Wals, J, Honkoop, AH, Erdkamp, FLG, de Jong, RS, Rodenburg, CJ, Vreugdenhil, G, Akkermans-Vogelaar, JM, Punt, CJA

Volltext

The first study published? von van Oijen, B.P.C., Erdkamp, F.L.G., Schouten, H.C., van der Kuy, P.H.M.

Volltext

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study von SIMONS, J. P. F. H. A, AARONSON, N. K, SCHOUTEN, H. C, DEMEDTS, M, HILLEN, H. F. P, BLIJHAM, G. H, WOUTERS, E. F. M, VANSTEENKISTE, J. F, TEN VELDE, G. P. M, MULLER, M. J, DRENTH, B. M, ERDKAMP, F. L. G, COBBEN, E. G. M, SCHOON, E. J, SMEETS, J. B. E

Volltext

Thorium dioxide-related haemangiosarcoma of the liver von VAN KAMPEN, R. J. W, ERDKAMP, F. L. G, PETERS, F. P. J

Volltext

Sclerosing peritonitis : an unusual cause of ascites in a patient with systemic lupus erythematosus von PEPELS, M. J. A. E, PETERS, F. P. J, MEBIS, J. J. I. R, CEELEN, Th. L, HOOFWIJK, A. C. M, ERDKAMP, F. L. G

Volltext

A lung cancer patient with painful fingers von Scholtes, B M J, Erdkamp, F L G, Peters, F P J

Volltext

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, place... von Fuchs, Charles S, Di Bartolomeo, Maria, Lonardi, Sara, Van Cutsem, Eric, Ilson, David H, Alsina, Maria, Chau, Ian, Lacy, Jill, Ducreux, Michel, Mendez, Guillermo Ariel, Alavez, Alejandro Molina, Takahari, Daisuke, Gorbounova, Vera, Wainberg, Zev A, Hegewisch-Becker, Susanna, Ferry, David, Lin, Ji, Das, Mayukh, Shah, Manish A, Karaseva, Nina A., Csoszi, Tibor, De Vita, Ferdinando, Sugimoto, Naotoshi, Kocsis, Judit, Csilla, Andràs, Bodoky, Gyorgy, Protsenko, Svetlana, Madi, Ayman, Wojcik, Elzbieta, Brenner, Baruch, Sarosiek, Tomasz, Peltola, Katriina Johanna, Bono, Peter, Aprile, Giuseppe, Falcone, Alfredo, Di Costanzo, Francesco, García Alfonso, Pilar, Senellart, Hélène, Petty, Russell, Samuel, Leslie, Hussein, Maen Abdelkarim, Won, Elizabeth, Bendell, Johanna Chock, Lorenzen, Sylvie, Melichar, Bohuslav, Pezet, Denis, Phelip, Jean-Marc, Kaen, Diego Lucas, Madhusudan, Srinivasan, Barone, Carlo, Fein, Luis Enrique, Gomez Villanueva, Angel, Prausova, Jana, Vidal Barrull, Joana, Yilmaz, Mette Karen Nytoft, DiCarlo, Brian Anthony, Geboes, Karen, Geva, Ravit, Kadowaki, Shigenori, Machida, Nozomu, Ramirez Godinez, Francisco Javier, Ruzsa, Agnes, Ford, Hugo, Lawler, William E., Petera, Jiri, Yamaguchi, Kensei, Hara, Hiroki, Beck, Joseph Thaddeus, Błasińska-Morawiec, Maria, Alcindor, Thierry, Bajaj, Madhuri, Berry, Scott, Dammrich, Daniel, Taieb, Julien, Ten Tije, A.J., Burkes, Ronald L., Cabanillas, Fernando, Firdaus, Irfan, Chua, Cynthia Coo, Hironaka, Shuichi, Hofheinz, Ralf-Dieter, Lim, Howard J., Nordsmark, Marianne, Verma, Udit, Wadsley, Jonathan, Yukisawa, Seigo, Pikiel, Joanna, Wojcik-Tomaszewska, Joanna, Brezden-Masley, Christine, Jang, Raymond Woo-Jun, Pribylova, Jana, Sakai, Daisuke, Bartoli, Maria Alejandra, Cats, A., Grootscholten, M.I., Dichmann, Robert Andrew, Hool, Hugo, Shaib, Walid, Tsuji, Akihito, Asmis, Timothy R.

Volltext

Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advan... von LALISANG, R. I, WILS, J. A, NORTIER, H. W, BURGHOUTS, J. T, HUPPERETS, P. S, ERDKAMP, F. L, SCHOUTEN, H. C, BLIJHAM, G. H

Volltext

Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer von Lalisang, R I, Voest, E E, Wils, J A, Nortier, J W, Erdkamp, F L, Hillen, H F, Wals, J, Schouten, H C, Blijham, G H

Volltext

Transanal total mesorectal excision and low anterior resection syndrome von van der Heijden, J A G, Qaderi, S M, Verhoeven, R, Custers, J A E, Klarenbeek, B R, Maaskant-Braat, A J G, de Wilt, J H W

Volltext

Hodgkin disease in the elderly. A registry‐based analysis von Erdkamp, Frans L., Breed, Wim P., Bosch, Leo J., Wijnen, Jac T. H., Blijham, Geert B.

Volltext

Influence on quality of life of chemotherapy scheduling for patients with advanced HER2-negative breast cancer von Claessens, A.K.M., Timman, R., Busschbach, J.J., Bouma, J.M., Rademaker-Lakhai, J.M., Erdkamp, F.L.G., Tjan-Heijnen, V.C.G., Bos, M.M.E.M.

Volltext

Intermittent versus continuous chemotherapy beyond first-line for patients with HER2-negative advanced breast cancer (BOOG 2010-02) von Erdkamp, F.L.G., Claessens, A.K.M., Lopez-Yurda, M., Bouma, J.M., van Tinteren, H., Rademaker-Lakhai, J.M., Honkoop, A.H., de Graaf, H., Tjan-Heijnen, V.C.G., Bos, M.M.E.M.

Volltext

Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative von Coebergh van den Braak, R. R. J., van Rijssen, L. B., van Kleef, J. J., Vink, G. R., Berbee, M., van Berge Henegouwen, M. I., Bloemendal, H. J., Bruno, M. J., Burgmans, M. C., Busch, O. R. C., Coene, P. P. L. O., Coupé, V. M. H., Dekker, J. W. T., van Eijck, C. H. J., Elferink, M. A. G., Erdkamp, F. L. G., van Grevenstein, W. M. U., de Groot, J. W. B., van Grieken, N. C. T., de Hingh, I. H. J. T., Hulshof, M. C. C. M., Ijzermans, J. N. M., Kwakkenbos, L., Lemmens, V. E. P. P., Los, M., Meijer, G. A., Molenaar, I. Q., Nieuwenhuijzen, G. A. P., de Noo, M. E., van de Poll-Franse, L. V., Punt, C. J. A., Rietbroek, R. C., Roeloffzen, W. W. H., Rozema, T., Ruurda, J. P., van Sandick, J. W., Schiphorst, A. H. W., Schipper, H., Siersema, P. D., Slingerland, M., Sommeijer, D. W., Spaander, M. C. W., Sprangers, M. A. G., Stockmann, H. B. A. C., Strijker, M., van Tienhoven, G., Timmermans, L. M., Tjin-a-Ton, M. L. R., van der Velden, A. M. T., Verhaar, M. J., Verkooijen, H. M., Vles, W. J., de Vos-Geelen, J. M. P. G. M., Wilmink, J. W., Zimmerman, D. D. E., van Oijen, M. G. H., Koopman, M., Besselink, M. G. H., van Laarhoven, H. W. M.

Volltext

Influence of primary tumour sidedness on survival after upfront primary tumour resection (PTR) in synchronous metastatic colon cancer (mCC) von van Rooijen, K L, Kurk, S A, van der Kruijssen, D E W, Elias, S, May, A M, Cats, A, Creemers, G-J M, Erdkamp, F L G, Loosveld, O J, Rodenburg, C J, Tanis, P J, Vink, G R, de Wilt, J H W, Punt, C J A, Koopman, M

Volltext

158P_PRIntermittent versus continuous chemotherapy beyond first-line for patients with HER2-negative advanced breast cancer (BOOG 2010-02) von Erdkamp, F L G, Claessens, A K M, Lopez-Yurda, M, Bouma, J M, van Tinteren, H, Rademaker-Lakhai, J M, Honkoop, A H, de Graaf, H, Tjan-Heijnen, V C G, Bos, M M E M

Volltext